NO20013945D0 - Fremstilling av isoflavonderivater - Google Patents

Fremstilling av isoflavonderivater

Info

Publication number
NO20013945D0
NO20013945D0 NO20013945A NO20013945A NO20013945D0 NO 20013945 D0 NO20013945 D0 NO 20013945D0 NO 20013945 A NO20013945 A NO 20013945A NO 20013945 A NO20013945 A NO 20013945A NO 20013945 D0 NO20013945 D0 NO 20013945D0
Authority
NO
Norway
Prior art keywords
preparation
isoflavone derivatives
isoflavone
derivatives
Prior art date
Application number
NO20013945A
Other languages
English (en)
Other versions
NO327749B1 (no
NO20013945L (no
Inventor
Andrew Heaton
Naresh Kumar
Original Assignee
Novogen Res Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novogen Res Pty Ltd filed Critical Novogen Res Pty Ltd
Publication of NO20013945D0 publication Critical patent/NO20013945D0/no
Publication of NO20013945L publication Critical patent/NO20013945L/no
Publication of NO327749B1 publication Critical patent/NO327749B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/38—2,3-Dihydro derivatives, e.g. isoflavanones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20013945A 1999-02-15 2001-08-14 Oksy-substituerte isoflavan-4-ol og isoflav-3-en-forbindelser samt fremgangsmater for fremstilling av de samme NO327749B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP8685A AUPP868599A0 (en) 1999-02-15 1999-02-15 Production of isoflavone derivatives
PCT/AU2000/000103 WO2000049009A1 (en) 1999-02-15 2000-02-15 Production of isoflavone derivatives

Publications (3)

Publication Number Publication Date
NO20013945D0 true NO20013945D0 (no) 2001-08-14
NO20013945L NO20013945L (no) 2001-08-14
NO327749B1 NO327749B1 (no) 2009-09-14

Family

ID=3812886

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013945A NO327749B1 (no) 1999-02-15 2001-08-14 Oksy-substituerte isoflavan-4-ol og isoflav-3-en-forbindelser samt fremgangsmater for fremstilling av de samme

Country Status (16)

Country Link
US (2) US20050143588A1 (no)
EP (1) EP1153020A4 (no)
JP (1) JP2002537295A (no)
CN (1) CN100564370C (no)
AU (2) AUPP868599A0 (no)
BR (1) BR0008222A (no)
CA (1) CA2362819C (no)
CZ (1) CZ20012920A3 (no)
HK (1) HK1041883B (no)
HU (1) HUP0105218A3 (no)
IL (2) IL144008A0 (no)
NO (1) NO327749B1 (no)
NZ (1) NZ538323A (no)
TR (1) TR200102367T2 (no)
WO (1) WO2000049009A1 (no)
ZA (1) ZA200106502B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE275959T1 (de) * 1992-05-19 2004-10-15 Graham Edmund Kelly Verwendung von isoflavon phyto-östrogen extrakten von soja oder klee
EP0979074A4 (en) * 1997-05-01 2003-07-09 Novogen Inc TREATMENT OR PREVENTION CLIMATE ACTION SYMPTOMS AND OSTEOPOROSIS
AUPP260798A0 (en) * 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
US20040072765A1 (en) * 1999-04-28 2004-04-15 Novogen Research Pty Ltd. Cardiovascular and bone treatment using isoflavones
AUPQ266199A0 (en) * 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
AUPQ520300A0 (en) * 2000-01-21 2000-02-17 Novogen Research Pty Ltd Food product and process
KR100436220B1 (ko) * 2001-08-30 2004-06-12 주식회사 네패스 바닥 반사방지막용 유기 중합체, 그의 제조방법 및 그를함유하는 조성물
EP1503751A4 (en) * 2002-04-09 2007-08-01 Novogen Res Pty Ltd THERAPEUTIC PROCESSES AND COMPOSITIONS WITH ISOFLAV-3-EN AND ISOFLAVAN STRUCTURES
US8668914B2 (en) 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
WO2004039327A2 (en) 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
JP2006504409A (ja) 2002-07-24 2006-02-09 チルドレンズ　ホスピタル　メディカル　センター 鏡像異性のエクオールを含有する組成物および製品、およびその製造方法
WO2004014886A1 (en) * 2002-08-07 2004-02-19 University Of Mississippi Antigiardial agents and use thereof
AU2003257264B2 (en) * 2002-09-06 2007-09-13 Novogen Research Pty Ltd Repair of DNA mutagenic damage
AU2002951271A0 (en) * 2002-09-06 2002-09-19 Novogen Research Pty Ltd Repair of dna mutagenic damage
CZ2005181A3 (cs) * 2002-09-23 2005-08-17 Novogen Research Pty Ltd Léčba stárnutí pokožky vlivem světla a aktinického poškození pokožky
AU2002951833A0 (en) 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
WO2006032086A1 (en) 2004-09-21 2006-03-30 Novogen Research Pty Ltd Chroman derivatives, medicaments and use in therapy
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
ATE532777T1 (de) 2004-09-21 2011-11-15 Marshall Edwards Inc Substituierte chromanderivate, medikamente und anwendungen in der therapie
US7528267B2 (en) 2005-08-01 2009-05-05 Girindus America, Inc. Method for enantioselective hydrogenation of chromenes
US7696363B2 (en) * 2005-12-02 2010-04-13 Yasoo Health Inc. Preparation of flavonoid compounds
US20070203227A1 (en) * 2006-02-24 2007-08-30 Herman Adlercreutz Isoflavan and isoflavene compounds and their use as angiogenesis inhibitors
EP2133080A1 (de) 2008-06-13 2009-12-16 Haelan Schweiz GmbH Zusammensetzungen enthaltend Equol
US7875735B2 (en) 2009-05-19 2011-01-25 Kaohsiung Medical University Processes for preparing isoflavonoids using 7-benzyloxy-3-(4-methoxyphenyl)-2H-1-benzopyran as a starting material
US7875736B2 (en) 2009-05-19 2011-01-25 Kaohsiung Medical University Intermediate compounds and processes for the preparation of 7-benzyloxy-3-(4-methoxyphenyl)-2H-1-benzopyran
JP6013349B2 (ja) 2010-11-01 2016-10-25 メイ ファーマ, インク.Mei Pharma, Inc. 癌の処置のためのイソフラボノイド化合物および方法
US9279082B2 (en) * 2011-01-20 2016-03-08 Merck Patent Gmbh Polymerisable compounds and the use thereof in liquid-crystal displays
US10420761B2 (en) 2013-03-15 2019-09-24 University Of Florida Research Foundation, Inc. Allosteric inhibitors of thymidylate synthase
AU2014248041A1 (en) * 2013-04-04 2015-10-01 The Administrators Of The Tulane Educational Fund Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells
CN103224481A (zh) * 2013-05-20 2013-07-31 黑龙江大学 一种去氢雌马酚的制备方法
ES2877712T3 (es) 2015-02-02 2021-11-17 Mei Pharma Inc Terapias combinadas para su uso en el tratamiento del cáncer de mama
WO2016209688A1 (en) 2015-06-24 2016-12-29 University Of Florida Research Foundation, Incorporated Compositions for the treatment of cancer and uses thereof
CN107459554B (zh) * 2016-06-03 2021-03-30 首都医科大学 4’,7-二氧乙酰-apak-5-羟基异黄酮,其合成,活性和应用
CN111303106B (zh) * 2020-03-23 2023-06-02 武汉轻工大学 一种5,6-二乙酰氧基-7-羟基黄酮的制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518002C3 (de) * 1965-01-02 1975-01-23 Merck Patent Gmbh, 6100 Darmstadt Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel
DE1543749A1 (de) * 1966-02-16 1969-12-11 Merck Ag E Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
JPS5035393A (no) * 1973-08-01 1975-04-04
JPS576427B2 (no) * 1974-01-25 1982-02-04
JPS50160483A (no) * 1974-06-19 1975-12-25
US4264509A (en) * 1977-06-08 1981-04-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
US4366082A (en) * 1979-04-11 1982-12-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
GB8626344D0 (en) * 1986-11-04 1986-12-03 Zyma Sa Bicyclic compounds
JPH0832632B2 (ja) * 1988-03-08 1996-03-29 株式会社太田胃散 尿素窒素代謝改善剤
JPH02124883A (ja) * 1988-11-04 1990-05-14 Kitasato Inst:The 抗酸化作用を有するイソフラボン誘導体およびその製造法
JPH0640876A (ja) * 1992-07-23 1994-02-15 Kobe Steel Ltd 紫外線障害防御外用剤
JPH0640909A (ja) * 1992-07-23 1994-02-15 Kobe Steel Ltd スーパーオキシド・ディスムターゼ様活性剤
JPH0686682A (ja) * 1992-07-23 1994-03-29 Kobe Steel Ltd ４’，７，８−トリヒドロキシイソフラボンの製造方法
JPH06321752A (ja) * 1993-05-07 1994-11-22 Kao Corp 美白剤
HUT68558A (en) * 1993-07-20 1995-06-28 Chinoin Gyogyszer Es Vegyeszet Method for preparing isoflavon derivatives
WO1996039832A1 (en) * 1995-06-07 1996-12-19 Kung Patrick C Compounds and methods for promoting hair growth
JPH1059956A (ja) * 1996-08-22 1998-03-03 Kikkoman Corp 新規イソフラボン誘導体及びその製造法
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
AUPP112497A0 (en) * 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
EP1057825A4 (en) * 1998-01-27 2001-10-24 Shionogi & Co ISOFLAVANE DERIVATIVES AND IMMUNOSTIMULATING COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
WO2000049009A1 (en) 2000-08-24
HK1041883B (zh) 2010-04-23
CZ20012920A3 (cs) 2001-11-14
BR0008222A (pt) 2001-10-30
US7906660B2 (en) 2011-03-15
ZA200106502B (en) 2005-05-09
JP2002537295A (ja) 2002-11-05
US20050143588A1 (en) 2005-06-30
CA2362819A1 (en) 2000-08-24
CN100564370C (zh) 2009-12-02
CN1340048A (zh) 2002-03-13
EP1153020A4 (en) 2002-08-21
HK1041883A1 (en) 2002-07-26
TR200102367T2 (tr) 2001-11-21
AUPP868599A0 (en) 1999-03-11
NZ538323A (en) 2005-10-28
NO327749B1 (no) 2009-09-14
EP1153020A1 (en) 2001-11-14
HUP0105218A3 (en) 2002-10-28
US20060217564A1 (en) 2006-09-28
IL144008A0 (en) 2002-04-21
IL144008A (en) 2011-03-31
NO20013945L (no) 2001-08-14
HUP0105218A1 (hu) 2002-07-29
CA2362819C (en) 2011-05-10
AU2651000A (en) 2000-09-04

Similar Documents

Publication Publication Date Title
NO20013945L (no) Fremstilling av isoflavonderivater
NO20030134L (no) Fremstilling av olefinderivater
AR028567A1 (es) Nuevos derivados de fenil-propargileter
AR028596A1 (es) Nuevos derivados de fenilglicina
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
DE50013404D1 (de) Substituierte 2-dialkylaminoalkylbiphenyl-derivate
PT1246817E (pt) Derivados de 4-fenil-1-piperazinilo, -piperidinilo e -tetra-hidropiridilo
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
NO20015505D0 (no) Fremstilling av komplekse karbohydrater
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
AR028607A1 (es) Derivados de 1,4-diazepan-2,5-diona
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
NO20020059D0 (no) Fremgangsmåte for fremstilling av dibenzotiazepinderivater
EE200200389A (et) Imidasooli uued derivaadid
IL149534A0 (en) Preparation of 3-substituted-4-arylquinolin-2-one derivatives
ATE273973T1 (de) Benzofuranderivate
NO20014383L (no) Fremgangsmåte for fremstilling av syklo-(Asp-DPhe-NMeVal-Arg- Gly)
NO20016030L (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
NO20032297D0 (no) Fremgangsmåte for fremstilling av distamycinderivater
NO20013044D0 (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
NO20022446D0 (no) Etere av O-desmetyl-venlafaxine
NO993313L (no) Derivater av 5-nitrofurfural
EE200200053A (et) Isoretinoiini valmistamise protsess
SE9902239D0 (sv) Kornisch bestående av flera delar

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees